Knowledge (XXG)

Krebs–Henseleit solution

Source 📝

260: 181:
Quan A, Leung SW, Lao TT, Man RY (December 2003). "5-hydroxytryptamine and thromboxane A2 as physiologic mediators of human umbilical artery closure".
301: 325: 168: 294: 108: 287: 39: 320: 132: 198: 104: 59: 271: 229: 218:"Krebs-Henseleit solution as a physiological buffer in perfused and superfused preparations" 190: 144: 112: 31: 17: 35: 217: 194: 314: 233: 267: 91: 67: 75: 47: 202: 259: 51: 148: 99: 87: 83: 55: 43: 97:
It has been used experimentally, for instance to study arteries
275: 216:Bailey, Leslie E.; Ong, Seok D. (August 1978). 295: 8: 169:curehunter.com > Krebs–Henseleit solution 302: 288: 124: 7: 256: 254: 274:. You can help Knowledge (XXG) by 222:Journal of Pharmacological Methods 86:, and sometimes supplemented with 25: 258: 1: 195:10.1016/S1071-5576(03)00149-7 133:"Krebs-Henseleit (KH) Buffer" 234:10.1016/0160-5402(78)90022-0 137:Cold Spring Harbor Protocols 171:Retrieved on April 14, 2010 143:: pdb.rec581. 1 June 2006. 342: 253: 183:J. Soc. Gynecol. Investig 107:preparations, and during 28:Krebs–Henseleit solution 18:Krebs-Henseleit solution 109:isolated muscle testing 270:-related article is a 326:Pharmacology stubs 149:10.1101/pdb.rec581 283: 282: 105:Langendorff heart 60:magnesium sulfate 16:(Redirected from 333: 304: 297: 290: 262: 255: 245: 244: 242: 240: 213: 207: 206: 178: 172: 166: 160: 159: 157: 155: 129: 113:skeletal muscles 21: 341: 340: 336: 335: 334: 332: 331: 330: 311: 310: 309: 308: 251: 249: 248: 238: 236: 215: 214: 210: 180: 179: 175: 167: 163: 153: 151: 131: 130: 126: 121: 81: 73: 65: 30:, developed by 23: 22: 15: 12: 11: 5: 339: 337: 329: 328: 323: 313: 312: 307: 306: 299: 292: 284: 281: 280: 263: 247: 246: 228:(2): 171–175. 208: 173: 161: 123: 122: 120: 117: 79: 71: 63: 36:Kurt Henseleit 24: 14: 13: 10: 9: 6: 4: 3: 2: 338: 327: 324: 322: 319: 318: 316: 305: 300: 298: 293: 291: 286: 285: 279: 277: 273: 269: 264: 261: 257: 252: 235: 231: 227: 223: 219: 212: 209: 204: 200: 196: 192: 188: 184: 177: 174: 170: 165: 162: 150: 146: 142: 138: 134: 128: 125: 118: 116: 114: 111:of mammalian 110: 106: 102: 101: 95: 93: 89: 85: 77: 69: 61: 57: 53: 49: 45: 41: 37: 33: 29: 19: 276:expanding it 268:pharmacology 265: 250: 237:. Retrieved 225: 221: 211: 189:(8): 490–5. 186: 182: 176: 164: 152:. Retrieved 140: 136: 127: 98: 96: 92:tromethamine 27: 26: 68:bicarbonate 42:containing 315:Categories 119:References 32:Hans Krebs 321:Solutions 76:phosphate 48:potassium 203:14662162 94:(THAM). 52:chloride 40:solution 100:ex vivo 88:albumin 84:glucose 56:calcium 38:, is a 201:  90:, and 58:(Ca), 54:(Cl), 46:(Na), 44:sodium 266:This 239:6 May 154:6 May 103:, in 62:(MgSO 50:(K), 272:stub 241:2021 199:PMID 156:2021 141:2006 70:(HCO 34:and 230:doi 191:doi 145:doi 82:), 78:(PO 74:), 66:), 317:: 224:. 220:. 197:. 187:10 185:. 139:. 135:. 115:. 303:e 296:t 289:v 278:. 243:. 232:: 226:1 205:. 193:: 158:. 147:: 80:4 72:3 64:4 20:)

Index

Krebs-Henseleit solution
Hans Krebs
Kurt Henseleit
solution
sodium
potassium
chloride
calcium
magnesium sulfate
bicarbonate
phosphate
glucose
albumin
tromethamine
ex vivo
Langendorff heart
isolated muscle testing
skeletal muscles
"Krebs-Henseleit (KH) Buffer"
doi
10.1101/pdb.rec581
curehunter.com > Krebs–Henseleit solution
doi
10.1016/S1071-5576(03)00149-7
PMID
14662162
"Krebs-Henseleit solution as a physiological buffer in perfused and superfused preparations"
doi
10.1016/0160-5402(78)90022-0
Stub icon

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.